(Q52941859)

English

Effect of statin (HMG-Co-A-Reductase Inhibitor) use on 1-year mortality and hospitalization rates in older patients with cardiovascular disease living in nursing homes.

scientific article published in August 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/12164995

Effect of statin (HMG-Co-A-Reductase Inhibitor) use on 1-year mortality and hospitalization rates in older patients with cardiovascular disease living in nursing homes. (English)

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/12164995

cardiovascular disease

1 reference

based on heuristic

inferred from title

2

object named as

Kate L Lapane

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/12164995

Charles B Eaton

1

object named as

Charles B Eaton

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/12164995

author name string

John B Murphy

3

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/12164995

Anne L Hume

4

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/12164995

language of work or name

0 references

publication date

1 August 2002

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/12164995

Journal of the American Geriatrics Society

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/12164995

50

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/12164995

8

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/12164995

1389-1395

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/12164995

Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Total Serum Cholesterol Levels and Mortality Risk as a Function of Age

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Ischemic heart disease risk factors after age 50.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Proportional hazards analysis of risk factors for coronary heart disease in individuals aged 65 or older. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

High blood cholesterol in elderly men and the excess risk for coronary heart disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Predictors of cardiovascular events and mortality in the Systolic Hypertension in the Elderly Program pilot project

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Validity of diagnostic and drug data in standardized nursing home resident assessments: potential for geriatric pharmacoepidemiology. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Prevalence, clinical correlates, and treatment of hypertension in elderly nursing home residents. SAGE (Systematic Assessment of Geriatric Drug Use via Epidemiology) Study Group.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Facility characteristics associated with hospitalization of nursing home residents: results of a national study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

The use of statins in acute coronary syndromes: the mechanisms behind the outcomes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Association of the Resident Assessment Instrument (RAI) with changes in function, cognition, and psychosocial status.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Calculating the number needed to treat for trials where the outcome is time to an event

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Coding of acute myocardial infarction. Clinical and policy implications

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Possible influence of the prospective payment system on the assignment of discharge diagnoses for coronary heart disease.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Coronary heart disease at 70, 75 and 79 years of age: a longitudinal study with special reference to sex differences and mortality

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Age-related trends in cardiovascular morbidity and physical functioning in the elderly: the Cardiovascular Health Study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Reliability estimates for the Minimum Data Set for nursing home resident assessment and care screening (MDS).

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Randomized clinical trials and recent patterns in the use of statins.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Use of cholesterol-lowering medications in the United States from 1991 to 1997.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1532-5415.2002.50360.X

21 January 2018

Identifiers

10.1046/J.1532-5415.2002.50360.X

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/12164995

1 reference

Europe PubMed Central

9 May 2018

http://europepmc.org/abstract/MED/12164995

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52941859&oldid=2063173982"